Citation Impact
Citing Papers
Oral cavity and oropharyngeal squamous cell carcinoma—an update
2015 Standout
Role of multidrug resistance protein 2 (MRP2) in chemoresistance and clinical outcome in oesophageal squamous cell carcinoma
2011
Quantitative multimodality imaging in cancer research and therapy
2014
Gene expression of histamine H1 receptor in guinea pig primary sensory neurons: a relationship between H1 receptor mRNA-expressing neurons and peptidergic neurons
1999
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Descending control of pain
2002 Standout
Molecular pharmacological aspects of histamine receptors
1995
Recognition and processing of cisplatin- and oxaliplatin-DNA adducts
2004
Diagnostic performance of post-treatment FDG PET or FDG PET/CT imaging in head and neck cancer: a systematic review and meta-analysis
2011
Molecular mechanisms of cisplatin resistance
2011 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Cellular processing of platinum anticancer drugs
2005 Standout
Oxaliplatin for the treatment of cisplatin-resistant cancer: A systematic review
2007
Artificial intelligence in radiology
2018 Standout
Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects
2011 Standout
Medical image fusion: A survey of the state of the art
2014
Histamine H1 receptor mRNA is expressed in capsaicin-insensitive sensory neurons with neuropeptide Y-immunoreactivity in guinea pigs
2001
Molecular properties and signalling pathways of the histamine H1receptor
1999
Pixel-level image fusion: A survey of the state of the art
2016 Standout
International Union of Pharmacology. XIII. Classification of Histamine Receptors
1997
Multimodal Machine Learning: A Survey and Taxonomy
2018 Standout
Works of Ichiro Higuchi being referenced
Prognostic Value of FDG-PET in Patients with Oropharyngeal Carcinoma Treated with Concurrent Chemoradiotherapy
2008
Molecular Cloning of the Guinea-Pig Histamine H1 Receptor Gene
1993
Diagnostic performance of fluorodeoxyglucose positron emission tomography/magnetic resonance imaging fusion images of gynecological malignant tumors: comparison with positron emission tomography/computed tomography
2010
Fusion Image of Positron Emission Tomography and Computed Tomography for the Diagnosis of Local Recurrence of Rectal Cancer
2005
Utility of response evaluation to neo-adjuvant chemotherapy by 18F-fluorodeoxyglucose-positron emission tomography in locally advanced esophageal squamous cell carcinoma
2010
Use of 18F-fluorodeoxyglucose-positron emission tomography to evaluate responses to neo-adjuvant chemotherapy for primary tumor and lymph node metastasis in esophageal squamous cell carcinoma
2008
The role of CT and18F-FDG PET in managing the neck in node-positive head and neck cancer after chemoradiotherapy
2008
18F-FDG PET/MRI fusion in characterizing pancreatic tumors: comparison to PET/CT
2011
Reduced MLH1 expression after chemotherapy is an indicator for poor prognosis in esophageal cancers.
2003